EPW
HRMY icon

Evolve Private Wealth’s Harmony Biosciences HRMY Stock Holding History

Evolve Private Wealth’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Buy
20,743
+2,111
+11% +$66.6K 0.05% 369
2026
Q1 		$522K Buy
+18,632
New +$611K 0.03% 558

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Evolve Private Wealth's HRMY Position: Q2 2026 in Review

Evolve Private Wealth increased its Harmony Biosciences (HRMY) stake by 11% in Q2 2026, buying an estimated $66.6K and bringing the position to 20,743 shares worth $755K. The position accounts for 0.05% of the portfolio, ranked #369.

Evolve Private Wealth first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Evolve Private Wealth held 20,743 shares of Harmony Biosciences worth $755K as of Q2 2026.
  • Evolve Private Wealth bought 2,111 Harmony Biosciences shares in Q2 2026, an estimated $66.6K.
  • Harmony Biosciences made up 0.05% of Evolve Private Wealth's portfolio in Q2 2026, its #369 holding.
  • Evolve Private Wealth first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.